| Literature DB >> 22806814 |
Ying Sun1, Hong-Yan Liu, Ling Mu, En-Jie Luo.
Abstract
Amplifying the variable (Fv or V) regions of immunoglobulins (Ig) has become a challenge in cloning antibody genes for phage display, a technique used to study protein-protein, protein-peptide, and protein-DNA interactions using bacteriophages to connect proteins with the genetic information that encodes them. Key parameters affecting the amplification of full antibody repertoires includes the availability of primers that can amplify as many V genes as possible; however the strategy used to design these primers and programs used to make the necessary alignments have not been well studied and clearly detailed in the literature. Here, we present a set of primers computationally designed by iCODEHOP based on a database of human germline Ig sequences. We used reverse transcription polymerase chain reaction (RT-PCR) protocols that would recognize the V(H) genes from human peripheral blood mononuclear cells. We identified the most highly conserved region in framework 1 and framework 4 of the Ig cDNA, and designed a set of degenerated 5' primers. The V(H) genes were successfully amplified by RT-PCR. This new primer has facilitated the creation of more diverse V(H) libraries than has been previously possible. Moreover, iCODEHOP improved the primer design efficiency and was found useful both for cloning unknown genes in gene families and for building V(H) gene libraries.Entities:
Mesh:
Substances:
Year: 2011 PMID: 22806814 PMCID: PMC7089251 DOI: 10.1007/s11274-011-0830-3
Source DB: PubMed Journal: World J Microbiol Biotechnol ISSN: 0959-3993 Impact factor: 3.312
Oligonucleotide primers for (RT-)PCR amplification of Ig VH genes
| Family or genea | Total no. of genes (%)b | Primer | Primer sequencec | Fold degd |
|---|---|---|---|---|
| VH1 | 30 (14) | VH1/5for | CAGTCCGGCGCCgargtbaaraa | 12 |
| VH2 | 21 (10) | VH2for | GGCCCCGCCCTGgtbaarccnac | 24 |
| VH3 | 84 (40) | VH3for | GGCGGCGGCstggtscagcc | 4 |
| VH4 | 62 (30) | VH4for1 | GGCCCCGGCytvgtbaarcc | 36 |
| VH4for2 | CAGGTGCAGCTGcarcartgggg | 4 | ||
| VH5 | 7 (3) | VH1/5for | 12 | |
| VH6 | 2 (1) | VH6for | CAGCTGCAGCAGTCCggnccngg | 16 |
| VH7 | 4 (2) | VH7for | GGCCACGAGCTGaaraarccngg | 4 |
| JH | 13 | Jreve | tgaggagacggtgaccrkkgtbcc | 24 |
aThe 37 pseudogenes in the human germline VH IgBLAST database were diverse in sequence and were not analysed for designing primers. 19 sequences were incomplete and were excluded from the analysis
bThe number of germline sequences present in the family analysed. The proportion of genes contributed by a given family to the total number of genes present in our VH database is given in parenthesis
cAll oligonucleotide primers are listed in the 5′–3′ direction. A CODEHOP primer is degenerate at the 3′ core region, which is shown in lower case, and is non-degenerate at the 5′ consensus clamp region, which is shown in upper case. IUPAC code for mix bases: M, a/c; R, a/g; W, a/t; Y, c/t; S, c/g; K, g/t; H, a/c/t; V, a/c/g; D, a/g/t; B, c/g/t; N, a/c/g/t
dFold degeneracy
eThe reverse primer is commonly used with all forward primers
Fig. 1Schematic diagram outlining the (RT-)PCR based strategy used. The (RT-)PCR strategy for amplifying the human rearranged/expressed VH genes using peripheral blood mononuclear cells as starting template is shown. The variable (VH), diversity (DH) and joining (JH) regions of the Ig H chain corresponding to the rearranged framework1 (FR1), complementary determining region1 (CDR1), FR2, CDR2, FR3, CDR3 and FR4 are indicated. The arrows pointing to the right and left indicate the orientation of the forward and reverse primers. The binding site for the 5′ and 3′ primer is located in FR1 and FR4, respectively
Fig. 2PCR amplification of V gene families from human peripheral blood mononuclear cells. PCR products obtained for individual VH gene families using primers described in Table 1, were resolved on agarose gels. The name of the forward primer is indicated. The expected size (~350 bp) of the PCR products were obtained for 7 VH gene families. M molecular weight marker (2,000, 1,000, 750, 500, and 250 bp)
Ig VH primers validation
| Forward primer | Recombinants analysed | Independent rearrangements | ||
|---|---|---|---|---|
| V | D | J | ||
| VH1/5for | 3 | IGHV5-51*01 | IGHD1-7*01 | IGHJ4*02 |
| IGHV1-8*01 | IGHD6-6*01 | IGHJ4*01 | ||
| IGHV5-51*01 | IGHD4-17*01 | IGHJ3*02 | ||
| VH2for | 4 | IGHV2-5*09 | IGHD3-16*02 | IGHJ4*02 |
| IGHV5-51*01 | IGHD4-17*01 | IGHJ4*01 | ||
| IGHV4-31*03 | IGHD2-15*01 | IGHJ5*02 | ||
| IGHV2-5*01 | IGHD-19*01 | IGHJ4*02 | ||
| VH3for | 2 | IGHV3-66*02 | IGHD2-8*02 | IGHJ3*02 |
| IGHV3-30*04 | IGHD1-26*01 | IGHJ4*02 | ||
| VH4for1 | 1 | IGHV4-59*01 | IGHD3-16*01 | IGHJ6*02 |
| VH4for2 | 1 | IGHV4-59*01 | IGHD7-27*01 | IGHJ4*02 |
| VH6for | 2 | IGHV6-1*02 | IGHD3-22*01 | IGHJ4*01 |
| IGHV4-31*10 | IGHD1-26*01 | IGHJ4*02 | ||
| VH7for | 1 | IGHV7-4-1*02 | IGHD4-23*01 | IGHJ1*01 |
Primer specificity validation by DNA sequencing. PCR products (see Fig. 2) were cloned in pmd18/T vector and up to four clones randomly selected and sequenced